Chemical site-selective protein modification: Development of a traceless vascular targeting ADC for cancer therapy por Bernardes, G, Neri, D, Davis, B

Targeted IL‐4 therapy synergizes with dexamethasone to induce a state of tolerance by promoting Treg cells and macrophages in mice with arthritis por Kawalkowska, J, Hemmerle, T, Pretto, F, Matasci, M, Neri, D, Williams, R

Stereo- and regiodefined DNA-encoded chemical libraries enable efficient tumour-targeting applications por Favalli, N, Bassi, G, Pellegrino, C, Millul, J, De Luca, R, Cazzamalli, S, Yang, S, Trenner, A, Mozaffari, NL, Myburgh, R, Moroglu, M, Conway, SJ, Sartori, AA, Manz, MG, Lerner, RA, Vogt, PK, Scheuermann, J, Neri, D